Ambarani, Anesan .

HRN: 26-30-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2026
CEFUROXIME 1.5GM (VIAL)
03/30/2026
04/06/2026
IV
260mg
Q8h
Pcap
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines